Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its third-quarter 2020 financial results after the close of the U.S. financial markets on Wednesday, November 4, 2020.

The company hosted a conference call on October 13, 2020, in conjunction with reporting preliminary third-quarter net sales. A replay of that call is available on Flexion’s corporate website: https://ir.flexiontherapeutics.com/events-and-presentations.

About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The ompany's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.

Contact:

Scott YoungVice President, Corporate Communications & Investor RelationsT: 781-305-7194syoung@flexiontherapeutics.com

Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more Flexion Therapeutics Charts.
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more Flexion Therapeutics Charts.